NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

September 7, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions

Knee Osteoarthritis

Interventions

DRUG

PSC-01

PSC-01 is a form of autologous cellular therapy resulting from the enzymatic processing of lipoaspirate to yield adipose-derived stromal vascular fraction cells.

Trial Locations (7)

60016

Cellular Orthopedics, Des Plaines

90025

The Orthohealing Center, Santa Monica

91942

Grossmont Orthopedic Medical Group, La Mesa

92011

San Diego Orthobiologics Medical Group, Carlsbad

92121

Synergy Orthopedic Specialists Medical Group, San Diego

97008

RestorePDX, Beaverton

07927

New Jersey Regenerative Institute, Cedar Knolls